Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203437 | 1.00 | PKM (0.44) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL3853115 | 1.00 | PKM (0.44) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL10923673 | 1.00 | PKM (0.44) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| Symclosene SCHEMBL8096505 | 0.89 | HPGD (0.40) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL11290710 | 0.82 | SMN1; SMN2 (0.42) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL10923681 | 0.77 | SMN1; SMN2 (0.45) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL27640914 | 0.74 | PKM (0.47) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL18181485 | 0.72 | PKM (0.46) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL742011 | 0.72 | PKM (0.46) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL204494 | 0.72 | PKM (0.58) | PKML3MBTL1HPGDSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012076699-A1 | BIOCIDE MICROCAPSULE FORMULATIONS CONTAINING STABILISED IODINE-CONTAINING COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2012-06-14 | — | — | WO | claimed |
| EP-2462805-A1 | Formulations containing stabilised compounds containing iodine | LANXESS Deutschland GmbH (DE) | 2012-06-13 | — | — | EP | claimed |
| US-11566140-B2 | Exterior coating composition | TROY CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-20200377738-A1 | EXTERIOR COATING COMPOSITION | TROY CORPORATION (US) | 2020-12-03 | — | — | US | disclosed |
| WO-2020243293-A1 | EXTERIOR COATING COMPOSITION | TROY CORPORATION (US) | 2020-12-03 | — | — | WO | disclosed |
| US-10798940-B2 | Penflufen polymer particles | LANXESS DEUTSCHLAND GMBH (DE) | 2020-10-13 | — | — | US | disclosed |
| EP-3428148-B1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) | 2020-07-08 | — | — | EP | disclosed |
| EP-3344663-B1 | POLYMER PARTICLE CONTAINING PENFLUFEN | LANXESS DEUTSCHLAND GMBH (DE) | 2020-02-19 | — | — | EP | disclosed |
| EP-3344664-B1 | BIOCIDAL MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2019-09-25 | — | — | EP | disclosed |
| US-10231459-B2 | Penflufen as a wood preservative against wood-destroying basidiomycetes | LANXESS DEUTSCHLAND GMBH (DE) | 2019-03-19 | — | — | US | disclosed |
| EP-3428148-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | Merial, Inc. (US) | 2019-01-16 | — | — | EP | disclosed |
| WO-1995026962-A1 | THIAZOLYLPYRAZOLINONES AND THEIR USE FOR PROTECTING TECHNICAL MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-10-12 | — | — | WO | disclosed |
| WO-1995021526-A1 | USE OF 1,3,2-BENZODITHIAZOL-1-OXIDES AS MICROBIOCIDES FOR PROTECTING TECHNICAL MATERIALS, AND CERTAIN 1,3,2-BENZODITHIAZOL-1-OXIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995014558-A1 | TIMBER PRESERVATIVE CONTAINING A COPPER COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-01 | — | — | WO | disclosed |
| WO-1995014383-A1 | ALKYL-N-PYRROLES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-01 | — | — | WO | disclosed |
| WO-1995011786-A1 | TIMBER PROTECTING MEDIUM CONTAINING A COPPER COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1995-05-04 | — | — | WO | disclosed |
| WO-1995006091-A1 | MOULD-RESISTANT EMULSION PAINTS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-02 | — | — | WO | disclosed |
| WO-1995004722-A1 | THIOCARBAMOYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-16 | — | — | WO | disclosed |
| WO-1994021734-A1 | PAINTS CONTAINING n-ALKYL-N-AZOLS AS PRESERVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
| EP-0277402-B1 | BIOCIDE | W.R. Grace & Co.-Conn. (US) | 1991-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10798940-B2 | Penflufen polymer particles | FAP, PUF60, MATR3 | PKM 767/4885L3MBTL1 3954/4885HPGD 96/4885 |
| US-10231459-B2 | Penflufen as a wood preservative against wood-destroying basidiomycetes | BLVRB, DCXR, PAH | PKM 636/4885L3MBTL1 2584/4885HPGD 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.